M.Com. (Business Economics) / Please refer to full text to view abstract

Employee Engagement is a critical business issue for the pharmaceutical industry especially owing to the highly competitive nature of this industry. This research postulates that factors can be identified that promote employee engagement in the pharmaceutical manufacturing industry. The purpose of the study is to research the factors that contribute to employee engagement in the pharmaceutical industry and to make recommendations in line with the results obtained that may be appropriate and significant to assist the pharmaceutical industry / Graduate School of Business Leadership / (M.B.A.)

This thesis investigates the 25-year transitional process of the Korean pharmaceutical industry from its initial focus on the imitative production of generic drugs to the development of new drugs. The catch-up dynamics of latecomer countries in science-intensive industries, such as the pharmaceutical industry, is an overlooked research topic in existing literature on innovation studies. This thesis provides an in-depth analysis of Korea's science-intensive catch-up and applies an ‘exploration and exploitation' framework to a latecomer setting and in a novel institutional and market context of the transitional phase. This thesis argues that the rate of change in the transition from imitating drugs to developing new drugs depends on the institutional and organisational mechanisms that enable a new form of technological learning, termed ‘exploratory learning'. This form of learning is often unfamiliar to firms in latecomer countries, whereas it is necessary for producing innovative drugs. That is, latecomers' institutional and organisational promotion of exploratory learning is related to a ‘pattern change' in the previously established institutional and organisational routines associated with imitative learning. The findings show that the rate of industrial transition in this sector was constrained by the problematic operation of S&T policies promoting key characteristics of exploratory learning, such as high-risk long-term learning as well as dense interactions between a diverse number of innovation actors. The findings also illuminate some latecomer firms' initial difficulties in managing the new mode of technological learning, and in strategically applying that mode of learning to overcome the barriers to moving through the transitional phase towards producing competitive innovation. The thesis also suggests that the nature of drugs as integral products, deeply grounded in science, makes it difficult to effectively promote institutional and organisational transformations in favour of exploratory learning.

<p>This study analyses the communication possibilities for pharmaceutical companies in Belgium. What communication tools can they use,which tools are the most effective, useful for the companies.</p>

This study analyses the communication possibilities for pharmaceutical companies in Belgium. What communication tools can they use,which tools are the most effective, useful for the companies.

Thesis (Ph. D.)--University of Texas at Austin, 2002. / Supervisor: Kenneth A. Lawson. Vita. Includes bibliographical references. Also available from UMI.

Thesis (M.A.) -- Central Connecticut State University, 2009. / Thesis advisor: Joanne DiPlacido. "... in partial fulfillment of the requirements for the degree of Master of Arts in Psychology." Includes bibliographical references (leaves 103-114). Also available via the World Wide Web.

No description available.

The aim of this dissertation project was to investigate the status of E-Business diffusion and the perception of the strategic value of E-Business in the Swiss pharmaceutical marketplace. / Thesis (DBusinessAdministration)--University of South Australia, 2008.

Thesis (DBA(DoctorateofBusinessAdministration))--University of South Australia, 2002.